This compound is a benzodiazepine impurity reference standard, specifically a derivative of chlordiazepoxide. It is characterized by an oxazireno ring fused to a benzodiazepine core, with chlorine and methyl substituents.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 17953-23-0
REDUCED MIDAZOLAM
benzodiazepine impurity reference standard
Ethyl 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
benzodiazepine impurity reference standard
7-Bromo-5-(6-methylpyridin-2-yl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one
benzodiazepine impurity reference standard
Bupivacaine N-Oxide Hydrochloride Salt
active pharmaceutical ingredient
17a-Dutasteride
active pharmaceutical ingredient
(S)-Mirabegron
active pharmaceutical ingredient
(2R)-Avibactam Sodium Salt
beta-lactamase inhibitor
8-chloro-N-methyl-9b-phenyl-3,5-dihydrooxazireno[2,3-d][1,4]benzodiazepin-4-imine
XSEVNHXJQHVDDQ-UHFFFAOYSA-N
CN=C1CN2C(O2)(C3=C(N1)C=CC(=C3)Cl)C4=CC=CC=C4
—